CIR resumes recruitment for Pfizer Phase 3 COVID-19 vaccine trial

This study involves comparing an investigational (study) vaccine against a placebo (injection with no active ingredient) to see if the vaccine can prevent COVID-19. The vaccine is given by injection. Adults 18-85 years old who are not pregnant, in good general health, and have not been previously diagnosed with COVID-19 can participate in the study. The study doctor will also assess whether you are at risk of COVID-19 infection before you can participate. Things the study doctor may consider include the type of work you do, your lifestyle, and any medical conditions you may have.

Contact us at 410-955-7283 or by email at or visit the CIR website.